Bictegravir Intermediate 1279032-31-3

 vemurafenib intermediate

Mesalazine Intermediate

1H-pyrrolo[2,3-b]pyridin-5-ol;Any product of above involved in patent will be used for research purposes only

tert-butyl 6-cyano-2-(2-(4-ethyl-3-iodophenyl)propan-2-yl)-1H-indole-3-carboxylate; Any product of above involved in patent will be used for research purposes only

6-cyano-2-(2-(4-ethyl-3-(4-morpholinopiperidin-1-yl)phenyl)propan-2-yl)-1H-indole-3-carboxylic acid; Any product of above involved in patent will be used for research purposes only

Antimalarial, AIDS drugs;  Any product of above involved in patent will be used for research purposes only

1-(2,2-diMethoxyethyl)-5-Methoxy-6-(Methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid; Any product of above involved in patent will be used for research purposes only

 Crizotinib is an anti-cancer drug acting as an ALK (anaplastic lymphoma kinase) . This is a Crizotinibintermediate. 

 Crizotinib is an anti-cancer drug acting as an ALK (anaplastic lymphoma kinase) . This is a Crizotinibintermediate. 

3-((2S,5S)-5-((3R,5R)-3-hydroxy-6-iodo-5-methylhept-6-en-1-yl)-4-methylenetetrahydrofuran-2-yl)propyl pivalate; Any product of above involved in patent will be used for research purposes only

methyl 2-((2R,4aS,6S,7R,8S,8aS)-7,8-bis((tert-butyldimethylsilyl)oxy)-6-((S,E)-1-((tert-butyldimethylsilyl)oxy)-3-iodoallyl)octahydropyrano[3,2-b]pyran-2-yl)acetate;Any product of above involved in patent will be used for research purposes only

 2-((2S,3S,4R,5R)-5-((S)-2,3-bis((tert-butyldimethylsilyl)oxy)propyl)-4-methoxy-3-(tosylmethyl)tetrahydrofuran-2-yl)acetaldehyde; Any product of above involved in patent will be used for research purposes only